Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a novel class of antidiabetic medications favored by T2DM patients due to their dual benefits of lowering blood glucose levels and promoting weight loss [6]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.